SOLUTION

Cardiovascular Solutions

According to the World Health Organization (WHO), cardiovascular diseases accounts for 32% of all deaths worldwide – around 17.9 million – and over three quarters of these take place in low-and middle-income countries.

Cardiovascular disease deaths are among the main causes of premature death in Saudi Arabia.

Of the 17 million premature deaths (under the age of 70) due to noncommunicable diseases in 2019, 38% were caused by cardiovascular disease.[1]

With 75% of cardiovascular deaths in low-and middle-income countries, Jameel Health is addressing this need, driving inclusivity and access to treatment, bringing innovative solutions in surgical techniques, imaging, and diagnostics to markets across the developing world.

Footnotes

[1] https://www.who.int/en/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)

Featured Partner

AVNeo^TM (Aortic Valve Neocuspidization) is a standardized revolutionary procedural technique used to reconstruct the aortic heart valve using the patient’s own pericardial tissue developed by Professor Shigeyuki Ozaki.

Partnering with Japanese innovative investment platform, Sanamedi, (previously JOMDD) and the Saudi Arabian Ministry of Health, Jameel Health is introducing this pioneering life-saving procedure into Saudi Arabia. Latest data showed the 10-year survival rate was 85.9% for AVNeo™ compared to less than 80% for alternative procedures.

Visit: AVNeo^TM